中华泌尿外科杂志
中華泌尿外科雜誌
중화비뇨외과잡지
CHINESE JOURNAL OF UROLOGY
2015年
4期
299-303
,共5页
赵力%沈文浩%印苏培%林荣凯%王起武%周占松
趙力%瀋文浩%印囌培%林榮凱%王起武%週佔鬆
조력%침문호%인소배%림영개%왕기무%주점송
前列腺增生%前列腺汽化电切术%外科手术
前列腺增生%前列腺汽化電切術%外科手術
전렬선증생%전렬선기화전절술%외과수술
Prostatic hyperplasia%Transurethral resection of the prostate%Surgical procedures,operative
目的 探讨经尿道前列腺电切术(TURP)治疗大体积(≥80 ml)良性前列腺增生(BPH)的安全性及有效性.方法 回顾性分析我院2010年1月至2013年1月采用TURP治疗的958例BPH患者的临床资料,根据前列腺大小分为大体积前列腺组(≥80 ml,A组)和中、小体积前列腺组(＜80 ml,B组).对比研究两组TURP手术的安全性和有效性.结果 A组276例,B组682例,两组年龄、术前美国麻醉医师协会评分差异无统计学意义(P＞0.05).A组术后血红蛋白及血清Na+浓度降低较多、术中切除腺体较多、手术时间较长,与B组比较差异均有统计学意义(P＜0.01),A、B两组围手术期并发症的改良外科手术并发症标准评级系统评分及术后留管时间、住院时间差异无统计学意义(P＞0.05).术后6个月A组最大尿流率(Qmax)从术前的(5.9±2.9) ml/s增至(17.1±8.2)ml/s,B组从术前的(6.1±3.0) ml/s增至(17.5±6.4) ml/s;A组国际前列腺症状评分(IPSS)从术前的23.7±6.1降至5.9±4.9,B组从术前的23.1±5.5降至6.2±4.4,两组组内比较差异均有统计学意义(P＜0.01).术后随访两组间IPSS、生命质量评分、Q.x、膀胱残余尿及远期并发症发生率差异均无统计学意义(P＞0.05).结论 TURP治疗大体积BPH具有和治疗中、小体积BPH相似的安全性和有效性.
目的 探討經尿道前列腺電切術(TURP)治療大體積(≥80 ml)良性前列腺增生(BPH)的安全性及有效性.方法 迴顧性分析我院2010年1月至2013年1月採用TURP治療的958例BPH患者的臨床資料,根據前列腺大小分為大體積前列腺組(≥80 ml,A組)和中、小體積前列腺組(＜80 ml,B組).對比研究兩組TURP手術的安全性和有效性.結果 A組276例,B組682例,兩組年齡、術前美國痳醉醫師協會評分差異無統計學意義(P＞0.05).A組術後血紅蛋白及血清Na+濃度降低較多、術中切除腺體較多、手術時間較長,與B組比較差異均有統計學意義(P＜0.01),A、B兩組圍手術期併髮癥的改良外科手術併髮癥標準評級繫統評分及術後留管時間、住院時間差異無統計學意義(P＞0.05).術後6箇月A組最大尿流率(Qmax)從術前的(5.9±2.9) ml/s增至(17.1±8.2)ml/s,B組從術前的(6.1±3.0) ml/s增至(17.5±6.4) ml/s;A組國際前列腺癥狀評分(IPSS)從術前的23.7±6.1降至5.9±4.9,B組從術前的23.1±5.5降至6.2±4.4,兩組組內比較差異均有統計學意義(P＜0.01).術後隨訪兩組間IPSS、生命質量評分、Q.x、膀胱殘餘尿及遠期併髮癥髮生率差異均無統計學意義(P＞0.05).結論 TURP治療大體積BPH具有和治療中、小體積BPH相似的安全性和有效性.
목적 탐토경뇨도전렬선전절술(TURP)치료대체적(≥80 ml)량성전렬선증생(BPH)적안전성급유효성.방법 회고성분석아원2010년1월지2013년1월채용TURP치료적958례BPH환자적림상자료,근거전렬선대소분위대체적전렬선조(≥80 ml,A조)화중、소체적전렬선조(＜80 ml,B조).대비연구량조TURP수술적안전성화유효성.결과 A조276례,B조682례,량조년령、술전미국마취의사협회평분차이무통계학의의(P＞0.05).A조술후혈홍단백급혈청Na+농도강저교다、술중절제선체교다、수술시간교장,여B조비교차이균유통계학의의(P＜0.01),A、B량조위수술기병발증적개량외과수술병발증표준평급계통평분급술후류관시간、주원시간차이무통계학의의(P＞0.05).술후6개월A조최대뇨류솔(Qmax)종술전적(5.9±2.9) ml/s증지(17.1±8.2)ml/s,B조종술전적(6.1±3.0) ml/s증지(17.5±6.4) ml/s;A조국제전렬선증상평분(IPSS)종술전적23.7±6.1강지5.9±4.9,B조종술전적23.1±5.5강지6.2±4.4,량조조내비교차이균유통계학의의(P＜0.01).술후수방량조간IPSS、생명질량평분、Q.x、방광잔여뇨급원기병발증발생솔차이균무통계학의의(P＞0.05).결론 TURP치료대체적BPH구유화치료중、소체적BPH상사적안전성화유효성.
Objective To discuss the safety and effectiveness of transurethral resection of the prostate (TURP) on large-size (≥ 80 ml) benign prostatic hyperplasia (BPH).Methods Retrospective analysis of 958 BPH patients in Southwest Hospital during January 2010 to January 2013 was conducted.The patients were grouped into ≥80 ml prostate group (Group A) and ＜80 ml prostate group (Group B) according to the volume of prostate.Comparison was made between the 2 groups on the safety and effectiveness of TURP.Results There were 276 patients in Group A and 682 in Group B.No significant differences were shown in average age and preoperative American society of anesthesiology score of Group A and B.Compared with Group B,decrement in hemoglobin level and blood Na+ concentration of Group A was more significant (P＜0.01).There were more prostate tissues excised and duration of the operations was longer (P＜0.01).No significant difference was observed in peri-operative complications graded by the modified Clavien classification system,catheter durations and durations of hospital stay between the 2 groups (P＞0.05).At 6 months after the surgery,average maximum urinary flow rate (Qmax) increased from 5.9±2.9 ml/s to 17.1±8.2 ml/s for Group A and 6.1±3.0 ml/s to 17.5±6.4 ml/s for Group B,both groups showed significant increase in Qmax after surgery(P＜0.01).Six months after surgery,international prostate symptom score (IPSS) of Group A decreased from 23.7±6.1 to 5.9±4.9 while IPSS of Group B decreased from 23.1±5.5 to 6.2±4.4,both groups showed a significant decrease (P＜0.01).No significant difference was shown in IPSS,quality of life,Qmax,postvoid residual urine volume and occurrence rate of long-term complications after 6 months between the 2 groups (P＞0.05).Conclusion TURP is as safe and effective in treating large-size BPH as treating medium and small-size BPH.
